Pre-diabetes and Diabetes
Last modified: March 13, 2025
In This Article:
References
Campbell Murdoch, et al. (2019). Adapting diabetes medication for low carbohydrate management of type 2 diabetes: a practical guide.
Tay J, Luscombe-Marsh ND, Thompson CH, et al. Comparison of low- and high-carbohydrate diets for type 2 diabetes management: a randomized trial. Am J Clin Nutr 2015;102:780–90.
Dyson P. Low carbohydrate diet and type 2 diabetes: what is the latest evidence? Diabetes Ther 2015;6:411–24
Yamada Y, Uchida J, Izumi H, et al. A non-calorie-restricted low-carbohydrate diet is effective as an alternative therapy for patients with type 2 diabetes. Intern Med 2014;53:13–19.
Saslow LR, Kim S, Daubenmier JJ, et al. A randomized pilot trial of a moderate carbohydrate diet compared to a very low carbohydrate diet in overweight or obese individuals with type 2 diabetes mellitus or prediabetes. PLoS ONE 2014;9:e91027.
Larsen RN, Mann NJ, Maclean E, et al. The effect of high-protein, low-carbohydrate diets in the treatment of type 2 diabetes: a 12 month randomised controlled trial. Diabetologia 2011;54:731–40.
van Wyk HJ, Davis RE, Davies JS. A critical review of low-carbohydrate diets in people with type 2 diabetes. Diabet Med 2016;33:148–57
San-Millán I, Brooks GA. Assessment of Metabolic Flexibility by Means of Measuring Blood Lactate, Fat, and Carbohydrate Oxidation Responses to Exercise in Professional Endurance Athletes and Less-Fit Individuals. Sports Med. 2018 Feb;48(2):467-479. doi: 10.1007/s40279-017-0751-x. PMID: 28623613.
Strasser B, Pesta D. Resistance training for diabetes prevention and therapy: experimental findings and molecular mechanisms. Biomed Res Int. 2013;2013:805217. doi: 10.1155/2013/805217. Epub 2013 Dec 22. PMID: 24455726; PMCID: PMC3881442.
Hordern MD, Dunstan DW, Prins JB, Baker MK, Singh MAF, Coombes JS. Exercise prescription for patients with type 2 diabetes and pre-diabetes: a position statement from Exercise and Sport Science Australia. Journal of Science and Medicine in Sport. 2012;15(1):25–31
Strasser B, Siebert U, Schobersberger W. Resistance training in the treatment of the metabolic syndrome: a systematic review and meta-analysis of the effect of resistance training on metabolic clustering in patients with abnormal glucose metabolism. Sports Medicine. 2010;40(5):397–415.
Grøntved A, Rimm EB, Willett WC, Andersen LB, Hu FB. A prospective study of weight training and risk of type 2 diabetes mellitus in men. Archives of Internal Medicine. 2012;172:1306–1312.
Holloszy JO. Invited review: exercise-induced increase in muscle insulin sensitivity. Journal of Applied Physiology. 2005;99(1):338–343.
Erickson ML, Jenkins NT, McCully KK. Exercise after You Eat: Hitting the Postprandial Glucose Target. Front Endocrinol (Lausanne). 2017 Sep 19;8:228. doi: 10.3389/fendo.2017.00228. PMID: 28974942; PMCID: PMC5610683.
Nygaard H, Tomten SE, Høstmark AT. Slow postmeal walking reduces postprandial glycemia in middle-aged women. Appl Physiol Nutr Metab. 2009 Dec;34(6):1087-92. doi: 10.1139/H09-110. PMID: 20029518.
Bellini A, Nicolò A, Rocchi JE, Bazzucchi I, Sacchetti M. Walking Attenuates Postprandial Glycemic Response: What Else Can We Do without Leaving Home or the Office? Int J Environ Res Public Health. 2022 Dec 24;20(1):253. doi: 10.3390/ijerph20010253. PMID: 36612575; PMCID: PMC9819328.
Bellini A., Nicolò A., Bazzucchi I., Sacchetti M. The Effects of Postprandial Walking on the Glucose Response after Meals with Different Characteristics. Nutrients. 2022;14:1080. doi: 10.3390/nu14051080.
Grajower MM, Horne BD. Clinical Management of Intermittent Fasting in Patients with Diabetes Mellitus. Nutrients. 2019 Apr 18;11(4):873. doi: 10.3390/nu11040873. PMID: 31003482; PMCID: PMC6521152.
Furmli S., Elmasry R., Ramos M., Fung J. Therapeutic use of intermittent fasting for people with type 2 diabetes as an alternative to insulin. BMJ Case Rep. 2018 doi: 10.1136/bcr-2017-221854
Corley B.T., Carroll R.W., Hall R.M., Weatherall M., Parry-Strong A., Krebs J.D. Intermittent fasting in Type 2 diabetes mellitus and the risk of hypoglycaemia: A randomized controlled trial. Diabet. Med. 2018;35:588–594. doi: 10.1111/dme.13595.
Carter S., Clifton P.M., Keogh J.B. Effect of intermittent compared with continuous energy restricted diet on glycemic control in patients with type 2 diabetes. JAMA Netw. Open. 2018;1:e180756. doi: 10.1001/jamanetworkopen.2018.0756.
Wei M., Brandhorst S., Shelehchi M., Mirzaei H., Cheng C.W., Budniak J., Groshen S., Mack W.J., Guen E., Di Biase S., et al. Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease. Sci. Transl. Med. 2017;9:eaai8700. doi: 10.1126/scitranslmed.aai8700.
Horne B.D., Muhlestein J.B., May H.T., Carlquist J.F., Lappé D.L., Bair T.L., Anderson J.L., Intermountain Heart Collaborative Study Group Relation of Routine, Periodic Fasting to Risk of Diabetes Mellitus, and Coronary Artery Disease in Patients Undergoing Coronary Angiography. Am. J. Cardiol. 2012;109:1558–1562. doi: 10.1016/j.amjcard.2012.01.379.
Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia. 2017 Sep;60(9):1577-1585. doi: 10.1007/s00125-017-4342-z. Epub 2017 Aug 3. PMID: 28776086; PMCID: PMC5552828.
Howlett HCS, Bailey CJ. Galegine and antidiabetic plants. In: Bailey CJ, Campbell IW, Chan JCN, Davidson JA, Howlett HCS, Ritz P, editors. Metformin—the gold standard. Chichester: Wiley; 2007. pp. 3–9
Mahapatra MK, Karuppasamy M, Sahoo BM. Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes. Rev Endocr Metab Disord. 2022 Jun;23(3):521-539. doi: 10.1007/s11154-021-09699-1. Epub 2022 Jan 7. PMID: 34993760; PMCID: PMC8736331.
Goldenberg RM, Steen O. Semaglutide: Review and Place in Therapy for Adults With Type 2 Diabetes. Can J Diabetes. 2019;43(2):136–145. doi: 10.1016/j.jcjd.2018.05.008.
Lan J, Zhao Y, Dong F, Yan Z, Zheng W, Fan J, Sun G. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. J Ethnopharmacol. 2015 Feb 23;161:69-81. doi: 10.1016/j.jep.2014.09.049. Epub 2014 Dec 10. PMID: 25498346.
Golbidi S, Badran M, Laher I. Diabetes and alpha lipoic Acid. Front Pharmacol. 2011 Nov 17;2:69. doi: 10.3389/fphar.2011.00069. PMID: 22125537; PMCID: PMC3221300.
Vallianou N, Evangelopoulos A, Koutalas P. Alpha-lipoic Acid and diabetic neuropathy. Rev Diabet Stud. 2009 Winter;6(4):230-6. doi: 10.1900/RDS.2009.6.230. Epub 2009 Dec 30. PMID: 20043035; PMCID: PMC2836194.
Havel PJ. A scientific review: the role of chromium in insulin resistance. Diabetes Educ. 2004;Suppl:2-14. PMID: 15208835.
Anderson RA. Chromium in the prevention and control of diabetes. Diabetes Metab. 2000 Feb;26(1):22-7. PMID: 10705100.
Anderson RA. Chromium, glucose intolerance and diabetes. J Am Coll Nutr. 1998 Dec;17(6):548-55. doi: 10.1080/07315724.1998.10718802. PMID: 9853533.
Kleefstra N, Bilo HJ, Bakker SJ, Houweling ST. Chroom en insulineresistentie [Chromium and insulin resistance]. Ned Tijdschr Geneeskd. 2004 Jan 31;148(5):217-20. Dutch. PMID: 14983576.
ELDerawi WA, Naser IA, Taleb MH, Abutair AS. The Effects of Oral Magnesium Supplementation on Glycemic Response among Type 2 Diabetes Patients. Nutrients. 2018 Dec 26;11(1):44. doi: 10.3390/nu11010044. PMID: 30587761; PMCID: PMC6356710.
Veronese N, Pizzol D, Smith L, Dominguez LJ, Barbagallo M. Effect of Magnesium Supplementation on Inflammatory Parameters: A Meta-Analysis of Randomized Controlled Trials. Nutrients. 2022 Feb 5;14(3):679. doi: 10.3390/nu14030679. PMID: 35277037; PMCID: PMC8838086.
Talaei, A., Mohamadi, M. & Adgi, Z. The effect of vitamin D on insulin resistance in patients with type 2 diabetes. Diabetol Metab Syndr 5, 8 (2013). https://doi.org/10.1186/1758-5996-5-8
Al-Shoumer KA, Al-Essa TM. Is there a relationship between vitamin D with insulin resistance and diabetes mellitus? World J Diabetes. 2015 Jul 25;6(8):1057-64. doi: 10.4239/wjd.v6.i8.1057. PMID: 26240702; PMCID: PMC4515445.
Wolden-Kirk H, Overbergh L, Christesen HT, Brusgaard K, Mathieu C. Vitamin D and diabetes: its importance for beta cell and immune function. Mol Cell Endocrinol. 2011 Dec 5;347(1-2):106-20. doi: 10.1016/j.mce.2011.08.016. Epub 2011 Aug 26. PMID: 21889571.
Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and diabetes. Endocrinol Metab Clin North Am. 2010 Jun;39(2):419-46, table of contents. doi: 10.1016/j.ecl.2010.02.013. PMID: 20511061.
Palomer X, González-Clemente JM, Blanco-Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab. 2008 Mar;10(3):185-97. doi: 10.1111/j.1463-1326.2007.00710.x. PMID: 18269634.
Get our free guide to magnesium supplementation!
Sign up for our newsletter and receive the guide for free, along with evidence-based health insights straight to your inbox.
-
Learn about the benefits of magnesium and which varieties provide the best benefits
-
Understand the different types of magnesium supplements
-
Get recommended dosage for optimal wellness